AETHLON MEDICAL, INC. Derivative Liability, Fair Value, Gross Liability
AETHLON MEDICAL, INC. (AEMD) had Derivative Liability, Fair Value, Gross Liability of $10.68 million as of 2014-03-31, per its 10-Q filed 2015-02-10.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2015-02-10
- 2014-03-31: Derivative Liability, Fair Value, Gross Liability $10.68M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2014-03-31 | $10.68M 10-Q · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |